Dipeptidyl peptidase-4 inhibitors -: Clinical data and clinical implications

被引：158

作者：

Ahren, Bo ^{[1
]}

机构：

[1] Lund Univ, Div Med, Dept Clin Sci, SE-22184 Lund, Sweden

来源：

DIABETES CARE | 2007年 / 30卷 / 06期

关键词：

D O I：

10.2337/dc07-0233

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1344 / 1350

页数：7

共 52 条

[1]

Vildagliptin:: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties [J].

Ahrén, B .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (04) :431-442

[2]

Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year [J].

Ahrén, B ;

Pacini, G ;

Foley, JE ;

Schweizer, A .

DIABETES CARE, 2005, 28 (08) :1936-1940

[3]

GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes [J].

Ahrén, B ;

Schmitz, O .

HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) :867-876

[4]

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes [J].

Ahrén, B ;

Landin-Olsson, M ;

Jansson, PA ;

Svensson, M ;

Holmes, D ;

Schweizer, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2078-2084

[5]

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes [J].

Ahrén, B ;

Gomis, R ;

Standl, E ;

Mills, D ;

Schweizer, A .

DIABETES CARE, 2004, 27 (12) :2874-2880

[6]

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].

Ahrén, B ;

Simonsson, E ;

Larsson, H ;

Landin-Olsson, M ;

Torgeirsson, H ;

Jansson, PA ;

Sandqvist, M ;

Båvenholm, P ;

Efendic, S ;

Eriksson, JW ;

Dickinson, S ;

Holmes, D .

DIABETES CARE, 2002, 25 (05) :869-875

[7]

Ahren B., 2005, CURRENT ENZYME INHIB, V1, P65, DOI [10.2174/1573408052952667, DOI 10.2174/1573408052952667]

[8]

AHREN B, 2005, THERAPY, V2, P207

[9]

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes [J].

Aschner, Pablo ;

Kipnes, Mark S. ;

Lunceford, Jared K. ;

Sanchez, Matilde ;

Mickel, Carolyn ;

Williams-Herman, Debora E. .

DIABETES CARE, 2006, 29 (12) :2632-2637

[10]

AZUMA K, 2006, 66 SCI SESS AM DIAB

← 1 2 3 4 5 6 →